Patients Information

The diagnosis of cancer is devastating to elderly cancer patients and their family

The diagnosis of cancer is devastating to elderly cancer patients and their family. Most often, elderly cancer patient are discriminated because of the perception that they may not tolerate the treatment. Elderly cancer patients are often denied curative treatment and excluded from clinical trials.

The myth of poor tolerance to treatment

Yet, the myth of poor tolerance to treatment is not supported by clinical data. Radiotherapy is often recommended for elderly cancer patients. However, because of the fear treatment toxicity, a palliative course is often preferred even when cure is possible.

New radiotherapy treatment techniques allow cure without added toxicity

New radiotherapy treatment techniques such as intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) deliver radiotherapy with precision, allowing cure without added toxicity because of the sparing of normal organs from excessive radiation.

We believe that IMRT and IGRT will provide the breakthrough for better quality of life in elderly cancer patients and dispel the myth of poor tolerance to curative treatment.

Advanced Technology

New radiotherapy treatment modalities such as intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) allow for sparing of the normal organs and decrease radiation treatment toxicities.

Intensity-modulated radiotherapy (IMRT)

Conventional radiotherapy technique uses multiple beams of radiation with the same intensity to treat the tumor leading to excessive high radiation dose of the normal tissues in the beam path.

Intensity-modulated radiotherapy (IMRT) is able to modulate the beam intensity through multiple small beams (beamlets) within the radiation beam such as when the radiation goes through the normal tissues, its intensity decreases and when it hit the cancer, its intensity increases.

Such physical properties allow IMRT to conform the radiation dose to the cancer delivering a high radiation dose to improve the chance for cure while sparing the adjacent normal tissues.The tumor is usually treated with a safety margin to decrease the chance of missing the tumor because of patient movement during treatment and the difficulty to reproduce the same treatment position every day.

Image-guided radiotherapy (IGRT)

Image-guided radiotherapy (IGRT) is a special technique of radiation delivery that combines the normal sparing property of IMRT with daily imaging before each radiation treatmen. Imaging of the tumor during treatment allows us to precisely target the tumor and decrease the volume of normal tissue in the safety margin.

IMRT and IGRT allows elderly cancer patients to tolerate radiation treatment better

As a result, IGRT allows further sparing of normal tissues and possibly escalating radiation dose to the cancer to kill it completely in some cancer that may be more resistant to radiation such as cancer of the kidney.

As the cancer shrinks during the treatment, we can re-plan the treatment to spare more normal tissues from radiation. The normal tissue sparing of IMRT and IGRT allows elderly cancer patients to tolerate radiation treatment better especially when radiotherapy is combined with chemotherapy to increase the patient chance for cure.

Complications may be minimized with IMRT and IGRT

Complications following head and neck cancer radiation such as hearing loss, damage to the jaw bone, swallowing difficulty requiring a feeding tube or resulting in aspiration of food into the lungs, hoarse voice, and dry mouth may be minimized with IMRT and IGRT.

Damage to the lungs, heart, small bowels, and bones may also be reduced following radiation of the chest and abdomen with these new radiotherapy techniques. All other normal organs close to the tumor may be spared from serious toxicity giving the patient a chance for better quality of life.

Two figures will be added in this section to illustrate the ability of IGRT to spare the normal tissues (lung) and tumor shrinkage during treatment (head and neck cancer).